start portlet menu bar

Просмотр веб-материалов

Display portlet menu
end portlet menu bar

Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

Домашняя страница Знания Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

The aim of this study was to compare the safety parameters of commercial non-attenuated and attenuated (Jeffers, 1975) Eimeria vaccines with EVALON®, a live attenuated coccidiosis vaccine for breeders and layers. 525 chickens were vaccinated orally at 1 day of age with either PBS (group 1), an attenuated vaccine (groups 2 and 4), including EVALON® (HIPRA) (group 2), or non-attenuated vaccines (groups 3 and 5).

Об этой статье

Опубликовано в

WVPA Congress, 2017

Дата

28 сент. 2017 г.

Авторы

Dardi, M.; Baratelli, M.; Boix, O.; Pagès, M.

Общий обзор

The outcomes of this trial suggest that both attenuation and also its grade might be important factors to take into account when selecting live coccidiosis vaccines. This study also supports the safety of EVALON®, a live attenuated vaccine designed to confer protection without compromising the health status of vaccinated animals.

Похожие продукты

Поделиться